Thyrocare Technologies, a company in the Healthcare Service Provider industry, reported revenue of ₹271 crore and net profit of ₹15 crore for the September 2026 quarter.
Thyrocare Technologies (NSE: THYROCARE) closed at ₹528.45 on 20 Nov 2026, up 3.9% over the past year. Its market capitalisation is ₹8,421 crore and it trades at 48.1 times earnings.
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.